Join
Live feed
·
INSIDERFilingvia Quantisnow
Viridian Therapeutics Inc. logo

Chief Operating Officer Beetham Thomas W. bought $117,050 worth of shares (5,000 units at $23.41), increasing direct ownership by 500% to 6,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VRDN· Viridian Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRDN (Viridian Therapeutics Inc.) and more on Quantisnow.